Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Qiankun Bao"'
Autor:
Ming Yuan, Mengqi Gong, Jinli He, Bingxin Xie, Zhiwei Zhang, Lei Meng, Gary Tse, Yungang Zhao, Qiankun Bao, Yue Zhang, Meng Yuan, Xing Liu, Cunjin Luo, Feng Wang, Guangping Li, Tong Liu
Publikováno v:
Redox Biology, Vol 52, Iss , Pp 102289- (2022)
Rationale: Endoplasmic reticulum (ER) stress and mitochondrial dysfunction are important mechanisms of atrial remodeling, predisposing to the development of atrial fibrillation (AF) in type 2 diabetes mellitus (T2DM). However, the molecular mechanism
Externí odkaz:
https://doaj.org/article/fd86208364634c038fe3d8ac3acfbe62
Publikováno v:
Frontiers in Physiology, Vol 12 (2021)
Aberrant sphingolipid metabolism contributes to cardiac pathophysiology. Emerging evidence found that an increased level of ceramide during the inflammatory phase of post-myocardial infarction (MI) served as a biomarker and was associated with cardia
Externí odkaz:
https://doaj.org/article/acc1e4ca8ffb468780e061395efb6d40
Autor:
Qiankun Bao, Bangying Zhang, Ya Suo, Chen Liu, Qian Yang, Kai Zhang, Ming Yuan, Meng Yuan, Yue Zhang, Guangping Li
Publikováno v:
eLife, Vol 9 (2020)
Intermittent hypoxia (IH) is the predominant pathophysiological disturbance in obstructive sleep apnea (OSA), known to be independently associated with cardiovascular diseases. However, the effect of IH on cardiac fibrosis and molecular events involv
Externí odkaz:
https://doaj.org/article/f79e0b8e242a4caaa509b8dfdd33d81d
Autor:
Ya Suo, Meng Yuan, Hongmin Li, Yue Zhang, Ying Li, Huaying Fu, Fei Han, Changhui Ma, Yuanyuan Wang, Qiankun Bao, Guangping Li
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
LCZ696 (sacubitril/valsartan) is an angiotensin receptor-neprilysin inhibitor and has shown beneficial effects in patients with heart failure. However, whether LCZ696 protects against left atrial (LA) and LA appendage (LAA) dysfunction is still uncle
Externí odkaz:
https://doaj.org/article/d2a98a1317084a6e974f68bd6ed24c80
Autor:
Yue Zhang, Meng Yuan, Ya Suo, Qian Yang, Shuai Shao, Ying Li, Yuanyuan Wang, Qiankun Bao, Tong Liu, Guangping Li
Publikováno v:
Clinical and experimental pharmacologyphysiologyREFERENCES. 49(8)
LCZ696, an angiotensin receptor-neprilysin inhibitor, has shown promising clinical efficacy in patients with heart failure (HF) with reduced ejection fraction. However, its potential effects on heart failure with preserved ejection fraction (HFpEF) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f48fdd8c22de497a6a727388380954e
https://pubmed.ncbi.nlm.nih.gov/35596518
https://pubmed.ncbi.nlm.nih.gov/35596518
Autor:
Bangying Zhang, Tong Liu, Xinpei Chen, Xiaofeng Mu, Gang Xu, Enzhao Liu, Qiankun Bao, Guangping Li
Publikováno v:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
BACKGROUND Atrial fibrillation (AF) is the most common persistent arrhythmia that can cause complications (including stroke). Therefore, its diagnosis and treatment require increased attention. Although beta-2 microglobulin (b2-MG) is a novel marker
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20055e8cf7e9fa4fa63373398846e19b
https://pubmed.ncbi.nlm.nih.gov/34803158
https://pubmed.ncbi.nlm.nih.gov/34803158
Publikováno v:
Frontiers in Physiology, Vol 12 (2021)
Frontiers in Physiology
Frontiers in Physiology
Aberrant sphingolipid metabolism contributes to cardiac pathophysiology. Emerging evidence found that an increased level of ceramide during the inflammatory phase of post-myocardial infarction (MI) served as a biomarker and was associated with cardia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0215d1694fb55ee4da618582703442a7
https://www.frontiersin.org/articles/10.3389/fphys.2021.663480/full
https://www.frontiersin.org/articles/10.3389/fphys.2021.663480/full
Autor:
Yue Zhang, Ying Li, Rong Li, Gary Tse, Tong Liu, Qiankun Bao, Ya Suo, Guangping Li, Shuai Shao, Meng Yuan, Li Kang, Kai Rong
Publikováno v:
Life sciences. 280
Aims This study investigated the renal protective effects and mechanisms of angiotensin receptor-neprilysin inhibitor LCZ696 in mice with cardiorenal syndrome. Materials and methods Mice were divided into abdominal aortic ligation alone, or treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bd58738546dd6bf4e5e281505c91418
https://pubmed.ncbi.nlm.nih.gov/34102189
https://pubmed.ncbi.nlm.nih.gov/34102189
Autor:
Guangping Li, Xinghua Wang, Qiankun Bao, Ming Yuan, Ya Suo, Qian Yang, Yue Zhang, Mengqi Gong, Ying Li, Shuai Shao, Meng Yuan
Publikováno v:
Oxidative Medicine and Cellular Longevity, Vol 2021 (2021)
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity
Heart failure (HF) is a clinical syndrome caused by impairment of ventricular filling, ejection of blood, or both and is categorized as HF with reduced ejection fraction (HFrEF) or HF with preserved ejection fraction (HFpEF) based on left ventricular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c74290c17ba76f47172dbbe745bacfb
Autor:
Ya Suo, Bangying Zhang, Guangping Li, Yue Zhang, Qiankun Bao, Meng Yuan, Kai Zhang, Ming Yuan, Chen Liu, Qian Yang
Publikováno v:
eLife
eLife, Vol 9 (2020)
eLife, Vol 9 (2020)
Intermittent hypoxia (IH) is the predominant pathophysiological disturbance in obstructive sleep apnea (OSA), known to be independently associated with cardiovascular diseases. However, the effect of IH on cardiac fibrosis and molecular events involv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2efaec1d23949cade1d9460a685589ea
https://doi.org/10.7554/elife.49923
https://doi.org/10.7554/elife.49923